Bioharvest Sciences IncCanadian Securities Exchange:BHSCView on OTCQB
- LAST PRICE6.7500
- TODAY'S CHANGE (%)0.1200 (1.8100%)
- Bid / Lots6.5000/ 5
- Ask / Lots6.7500/ 12
- Open / Previous Close6.7300 / 6.6300
- Day Range
- 52 Week Range
- Volume1,900
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BHSC |
|---|---|---|
| 09:32 ET | 100 | 6.73 |
| 02:56 ET | 800 | 6.75 |
| 02:59 ET | 1000 | 6.75 |
Oct 23, 2024
BioHarvest Sciences Announces Record Preliminary Third Quarter 2024 Financial Results, from 8:32AM ET on Wednesday Oct 23, 2024 by Dow Jones
8:32AM ET on Wednesday Oct 23, 2024 by Dow Jones
Oct 16, 2024
BioHarvest Sciences to Participate in LD Micro Main Event XVII Conference on October 30, 2024, from 8:49AM ET on Wednesday Oct 16, 2024 by Dow Jones
8:49AM ET on Wednesday Oct 16, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Bioharvest Sciences Inc | 114.9M | -4.2x | --- |
Happy Belly Food Group Inc | 77.4M | -39.6x | --- |
Fresh Factory BC Ltd | 42.0M | -22.6x | --- |
Burcon NutraScience Corp | 17.1M | -2.2x | --- |
Organto Foods Inc | 2.2M | -0.1x | --- |
Planting Hope Co Inc | 1.2M | -0.1x | --- |
Company Information
BioHarvest Sciences Inc. is a Canada-based biotechnology company. The Company offers Botanical Synthesis, its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. The Company is leveraging its Botanical Synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals: as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. The Company operates through two segments: Nutraceuticals and Pharmaceuticals. The Company offers a polyphenol/antioxidant superfruit product called VINIA, which is a red grape powder that supplies the benefits of red wine consumption but without the sugar, calories and alcohol found in wine.
Contact Information
- Headquarters
- 1140 - 625 Howe StreetVANCOUVER, BC, Canada V6C 2T6
- Phone
- 604-622-1186
- Fax
- 604-622-1186
Executives
- Chairman of the Board, President
- Zaki Rakib
- Chief Executive Officer
- Ilan Sobel
- Chief Financial Officer
- Alan Rootenberg
- Chief Operating Officer
- Ilana Belzer
- Chief Technology Officer
- Yochi Hagay
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $114.9M |
|---|---|
Revenue (TTM) | $26.6M |
Shares Outstanding | 17.3M |
Bioharvest Sciences Inc does not pay a dividend. | |
Beta | 1.49 |
EPS | $-1.62 |
Book Value | $-1.51 |
P/E Ratio | -4.2x |
Price/Sales (TTM) | 4.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -40.54% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
